DIA465.06-0.42 -0.09%
SPY655.83+0.59 0.09%
QQQ584.98+0.67 0.11%

China Life Insurance (SEHK:2628) Q4 Loss Challenges Bullish Earnings Growth Narrative

Simply Wall St·03/26/2026 10:14:52
Listen to the news

China Life Insurance (SEHK:2628) has wrapped up FY 2025 with a mixed final quarter, reporting Q4 revenue of CNY 39.3b and a basic EPS loss of CNY 0.48, set against trailing 12 month EPS of CNY 5.45 on revenue of CNY 352.1b. Investors are weighing recent 44.1% earnings growth and a net profit margin of 43.8% against forecasts of an 8.1% annual earnings decline over the next three years. Over recent periods the company has seen quarterly revenue move from CNY 58.9b in Q4 2024 to CNY 64.3b in Q1 2025 and up to CNY 173.7b in Q3 2025. Quarterly EPS shifted from CNY 0.09 to CNY 1.02, CNY 0.43 and CNY 4.50 before the latest quarterly loss, leaving investors focused on how resilient those high margins really are.

See our full analysis for China Life Insurance.

With the numbers on the table, the next step is to see how this earnings profile lines up with the key stories investors already follow about China Life Insurance and where those narratives might need a rethink.

See what the community is saying about China Life Insurance

SEHK:2628 Revenue & Expenses Breakdown as at Mar 2026
SEHK:2628 Revenue & Expenses Breakdown as at Mar 2026

44.1% earnings growth meets a Q4 loss

  • Over the last twelve months, China Life Insurance generated CNY 154.1b in net income and CNY 5.45 in EPS, yet Q4 alone showed a net loss of CNY 13.7b on CNY 39.3b of revenue, which is a sharp contrast to the very profitable Q3 result of CNY 126.9b in net income on CNY 173.7b of revenue.
  • Bears point to this swing from a profitable first three quarters of FY 2025 to a Q4 loss as backing concerns about forecast earnings declines of about 8.1% per year over the next three years, yet
    • trailing twelve month earnings growth of 44.1% and net profit margins at 43.8% compared with 34% the prior year show that recent full year profitability remains high even with the weak quarter included, and
    • consensus narrative comments about pressure on managing liability costs and the impact of interest rates on product mix sit directly against the record CNY 608.2b in gross written premiums and a 25.1% increase in the value of new business cited in the inputs, so the Q4 loss will likely be a key data point bears keep highlighting.

Margins strong at 43.8% but forecast to shrink

  • Net profit margin over the last year is 43.8% compared with 34% the prior year, while analysts expect profit margins to shrink to 17.1% in around three years even as revenue is forecast to grow about 29.8% per year.
  • Consensus narrative stresses that managing comprehensive liability costs and adapting the product mix could weigh on profitability, which lines up with
    • the assumption that earnings will move from CNY 170.2b today to CNY 135.4b by around March 2029, even though revenue is assumed to reach CNY 792.5b over that period, and
    • the view that maintaining the current net investment return rate may be difficult as interest rates stabilise, which ties back to the expectation that margins fall from 45.8% today to 17.1% despite the current trailing twelve month margin of 43.8%.

With margins at 43.8% over the last year yet analysts assuming they fall to 17.1%, it is worth understanding how bulls and bears are both reading the same set of numbers before you decide how much weight to give these forecasts. 🐂 China Life Insurance Bull Case

Low 4.1x P/E against CNY 25.04 price

  • At a current share price of HK$25.04, the trailing P/E of 4.1x compares with an Asian Insurance industry average of 11.4x and a peer average of 14.5x, while the latest analyst price target in the inputs is HK$35.84 and the DCF fair value is CNY 106.98, both higher than the current price.
  • Critics highlight that analysts still forecast earnings to decline by around 8.1% per year over the next three years and cite an unstable dividend track record, which they argue helps explain why the market assigns a lower multiple, yet
    • the same data showing a 44.1% earnings growth rate over the last year and improved margins to 43.8% suggests the trailing profitability profile looks strong on its own terms, and
    • the consensus narrative pointing to a high core solvency ratio of 154.58% and a comprehensive solvency ratio of 211.64% frames the low P/E and discount to the DCF fair value of CNY 106.98 as something investors may compare carefully against the forecast earnings decline and dividend history.

For readers who lean toward the cautious side, the combination of a 4.1x P/E, an unstable dividend history, and forecasts of shrinking margins gives plenty of material to stress test before making any decisions. 🐻 China Life Insurance Bear Case

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for China Life Insurance on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

Given the mix of cautious and optimistic signals here, it makes sense to review the full picture yourself and decide where you stand. To weigh up both sides of the story, check the 5 key rewards and 2 important warning signs.

See What Else Is Out There

The mix of a Q4 loss, forecasts of an 8.1% annual earnings decline and expectations for margins to shrink suggests earnings quality and stability are real concerns.

If you want ideas that aim to reduce that kind of uncertainty, check out the 286 resilient stocks with low risk scores to focus on companies with more resilient risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.